Recerca

Leucèmia i hemopaties pediàtriques

Buscador de publicacions

Publicacions

  • L S, Gasior M, de Paz R, Querol S, Bueno D, Fernández L, Marsal-Ricoma J, Sastre A, Gimeno R, Alonso L, Badell I, López-Granados E, Torres J, Medina L, Torrent M, Diaz de Heredia C, Escudero A and Pérez-Martínez A.

    Unexpected High Incidence of Human Herpesvirus-6 Encephalitis after Naive T Cell-Depleted Graft of Haploidentical Stem Cell Transplantation in Pediatric Patients.

    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION . 24(11): 2316-2323. Nº de cites: 26

    [doi:10.1016/j.bbmt.2018.07.016]

  • Torrebadell-Burriel M, Diaz-Beya M, Kalko SG, Pratcorona M, Nomdedeu J, Navarro A, Gel B, Brunet S, Sierra J, Camós-Guijosa M and Esteve J.

    A 4-gene expression prognostic signature might guide post-remission therapy in patients with intermediate-risk cytogenetic acute myeloid leukemia.

    LEUKEMIA & LYMPHOMA . 59(10): 2394-2404. Nº de cites: 11

    [doi:10.1080/10428194.2017.1422859]

  • Berrueco R, Dapena JL, Sebastián E and Sastre A.

    Controversies in the treatment of paediatric immune thrombocytopenia

    ANALES DE PEDIATRIA . 89(3): . Nº de cites: 4

    [doi:10.1016/j.anpedi.2018.06.010]

  • Vega-García N, Malatesta R, Estella-Aguado MC, Pérez-Jaume S, Esperanza-Cebollada E, Torrebadell-Burriel M, Català-Temprano A, Gassiot S, Berrueco R, Ruiz-Llobet A, Alonso-Saladrigues A, Mesegue-Meda M, Pont-Martí S, Rives-Solà S and Camós-Guijosa M.

    Paediatric patients with acute leukaemia and KMT2A (MLL) rearrangement show a distinctive expression pattern of histone deacetylases

    BRITISH JOURNAL OF HAEMATOLOGY . 182(4): 542-553. Nº de cites: 7

    [doi:10.1111/bjh.15436]

  • Pérez-Rodríguez A, Batlle J, Corrales I, Borràs N, Rodríguez-Trillo Á, Lourés E, Cid AR, Bonanad S, Cabrera N, Moret A, Parra R, Mingot-Castellano ME, Navarro N, Altisent C, Pérez-Montes R, Marcellini S, Moreto A, Herrero S, Soto I, Fernández Mosteirín N, Jiménez-Yuste V, Alonso N, de Andrés Jacob A, Fontanes E, Campos R, Paloma MJ, Bermejo N, Berrueco R, Mateo J, Arribalzaga K, Marco P, Palomo Á, Castro Quismondo N, Iñigo B, Nieto MDM, Vidal R, Martínez MP, Aguinaco R, Tenorio M, Ferreiro M, García-Frade J, Rodríguez-Huerta AM, Cuesta J, Rodríguez-González R, García-Candel F, Dobón M, Aguilar C, Batlle F, Vidal F and López-Fernández MF.

    Role of multimeric analysis of von Willebrand factor (VWF) in von Willebrand disease (VWD) diagnosis: Lessons from the PCM-EVW-ES Spanish project

    PLoS One . 13(6): . Nº de cites: 4

    [doi:10.1371/journal.pone.0197876]

  • Maude SL, Laetsch TW, Buechner J, Rives-Solà S, Boyer M, Bittencourt H, Bader P, Verneris MR, Stefanski HE, Myers GD, Qayed M, De Moerloose B, Hiramatsu H, Schlis K, Davis KL, Martin PL, Nemecek ER, Yanik GA, Peters C, Baruchel A, Boissel N, Mechinaud F, Balduzzi A, Krueger J, June CH, Levine BL, Wood P, Taran T, Leung M, Mueller KT, Zhang Y, Sen K, Lebwohl D, Pulsipher MA and Grupp SA.

    Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.

    NEW ENGLAND JOURNAL OF MEDICINE . 378(5): 439-448. Nº de cites: 3212

    [doi:10.1056/NEJMoa1709866]

  • Llaudet-Planas E, Vives-Corrons JL, Rizzuto V, Gómez-Ramírez P, Sevilla Navarro J, Coll Sibina MT, García-Bernal M, Ruiz-Llobet A, Badell-Serra I, Velasco-Puyó P, Dapena JL and Mañú-Pereira MM.

    Osmotic gradient ektacytometry: A valuable screening test for hereditary spherocytosis and other red blood cell membrane disorders.

    INT J LAB HEMATOL . 40(1): 94-102. Nº de cites: 51

    [doi:10.1111/ijlh.12746]

  • Lipka DB, Witte T, Toth R, Yang J, Wiesenfarth M, Nollke P, Fischer A, Brocks D, Gu Z, Park J, Strahm B, Wlodarski M, Yoshimi A, Claus R, Lubbert M, Busch H, Boerries M, Hartmann M, Schonung M, Kilik U, Langstein J, Wierzbinska JA, Pabst C, Garg S, Català-Temprano A, De Moerloose B, Dworzak M, Hasle H, Locatelli F, Masetti R, Schmugge M, Smith O, Stary J, Ussowicz M, van den Heuvel-Eibrink MM, Assenov Y, Schlesner M, Niemeyer C, Flotho C and Plass C.

    RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia.

    NATURE COMMUNICATIONS . 8(1): 2126-2126. Nº de cites: 72

    [doi:10.1038/s41467-017-02177-w]

  • Borràs N, Batlle J, Pérez-Rodríguez A, López-Fernández MF, Rodríguez-Trillo Á, Lourés E, Cid AR, Bonanad S, Cabrera N, Moret A, Parra R, Mingot-Castellano ME, Balda I, Altisent C, Pérez-Montes R, Fisac RM, Iruín G, Herrero S, Soto I, de Rueda B, Jimimenez-Yuste V, Alonso N, Vilariño D, Arija O, Campos R, Paloma MJ, Bermejo N, Berrueco R, Mateo J, Arribalzaga K, Marco P, Palomo Á, Sarmiento L, Iñigo B, Nieto MDM, Vidal R, Martínez MP, Aguinaco R, César JM, Ferreiro M, García-Frade J, Rodríguez-Huerta AM, Cuesta J, Rodríguez-González R, García-Candel F, Cornudella R, Aguilar C, Vidal F and Corrales I.

    Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): comprehensive genetic analysis by next-generation sequencing of 480 patients

    HAEMATOLOGICA . 102(12): 2005-2014. Nº de cites: 32

    [doi:10.3324/haematol.2017.168765]

  • Robles-Valero J, Lorenzo-Martín LF, Menacho-Márquez M, Fernández-Pisonero I, Abad A, Camós-Guijosa M, Toribio ML, Espinosa L, Bigas A and Bustelo XR.

    A Paradoxical Tumor-Suppressor Role for the Rac1 Exchange Factor Vav1 in T Cell Acute Lymphoblastic Leukemia.

    Cancer Cell . 32(5): 608-6239. Nº de cites: 26

    [doi:10.1016/j.ccell.2017.10.004]